Nanovesicle-mediated delivery of anticancer agents effectively induced cell death and regressed intrahepatic tumors in athymic mice

Chun, 2011, Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma, J Surg Oncol, 103, 148, 10.1002/jso.21786 Torre, 2015, Global cancer statistics, 2012, CA Cancer J Clin, 65, 87, 10.3322/caac.21262 Thorgeirsson, 2002, Molecular pathogenesis of human hepatocellular carcinoma, Nat Genet, 31, 339, 10.1038/ng0802-339 George, 2015, Noncoding RNA as therapeutic targets for hepatocellular carcinoma, Semin Liver Dis, 35, 63, 10.1055/s-0034-1397350 Di Leva, 2014, MicroRNAs in cancer, Annu Rev Pathol, 9, 287, 10.1146/annurev-pathol-012513-104715 Ha, 2014, Regulation of microRNA biogenesis, Nat Rev Mol Cell Biol, 15, 509, 10.1038/nrm3838 Park, 2011, miR-221 silencing blocks hepatocellular carcinoma and promotes survival, Cancer Res, 71, 7608, 10.1158/0008-5472.CAN-11-1144 Dubbelboer, 2014, Treatment of intermediate stage hepatocellular carcinoma: a review of intrahepatic doxorubicin drug-delivery systems, Ther Deliv, 5, 447, 10.4155/tde.14.11 Yang, 2015, MicroRNA-522 reverses drug resistance of doxorubicin-induced HT29 colon cancer cell by targeting ABCB5, Mol Med Rep, 12, 3930, 10.3892/mmr.2015.3890 Qu, 2015, MicroRNA-195 chemosensitizes colon cancer cells to the chemotherapeutic drug doxorubicin by targeting the first binding site of BCL2L2 mRNA, J Cell Physiol, 230, 535, 10.1002/jcp.24366 Davis, 2008, Nanoparticle therapeutics: an emerging treatment modality for cancer, Nat Rev Drug Discov, 7, 771, 10.1038/nrd2614 Johnsen, 2014, A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy, Biochim Biophys Acta, 1846, 75 Vlassov, 2012, Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials, Biochim Biophys Acta, 1820, 940, 10.1016/j.bbagen.2012.03.017 Lee, 2012, Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy, Hum Mol Genet, 21, R125, 10.1093/hmg/dds317 El Andaloussi, 2013, Exosomes for targeted siRNA delivery across biological barriers, Adv Drug Deliv Rev, 65, 391, 10.1016/j.addr.2012.08.008 Valadi, 2007, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, Nat Cell Biol, 9, 654, 10.1038/ncb1596 Ettelaie, 2014, Characterization of physical properties of tissue factor-containing microvesicles and a comparison of ultracentrifuge-based recovery procedures, J Extracell Vesicles, 3, 23592, 10.3402/jev.v3.23592 Haga, 2015, Tumour cell-derived extracellular vesicles interact with mesenchymal stem cells to modulate the microenvironment and enhance cholangiocarcinoma growth, J Extracell Vesicles, 4, 24900, 10.3402/jev.v4.24900 Barger, 2016, Extracellular miRNAs as biomarkers in cancer, Food Chem Toxicol, 98, 66, 10.1016/j.fct.2016.06.010 Ohno, 2013, Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells, Mol Ther, 21, 185, 10.1038/mt.2012.180 Mitchell, 2012, E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells, J Control Release, 160, 609, 10.1016/j.jconrel.2012.02.018 Ishida, 2008, Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes, Int J Pharm, 354, 56, 10.1016/j.ijpharm.2007.11.005 Abu Lila, 2014, Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery, J Pharm Sci, 103, 557, 10.1002/jps.23823 Baddela, 2016, Physicochemical biomolecular insights into buffalo milk-derived nanovesicles, Appl Biochem Biotechnol, 178, 544, 10.1007/s12010-015-1893-7 Suetsugu, 2013, Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models, Adv Drug Deliv Rev, 65, 383, 10.1016/j.addr.2012.08.007 Ahmed, 2015, Exosome-mediated delivery of the intrinsic C-terminus domain of PTEN protects it from proteasomal degradation and ablates tumorigenesis, Mol Ther, 23, 255, 10.1038/mt.2014.202 Munagala, 2016, Bovine milk-derived exosomes for drug delivery, Cancer Lett, 371, 48, 10.1016/j.canlet.2015.10.020 Ha, 2016, Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges, Acta Pharm Sin B, 6, 287, 10.1016/j.apsb.2016.02.001 Bae, 2011, Targeted drug delivery to tumors: myths, reality and possibility, J Control Release, 153, 198, 10.1016/j.jconrel.2011.06.001 Mishra, 2013, Efficient hepatic delivery of drugs: novel strategies and their significance, Biomed Res Int, 2013, 382184, 10.1155/2013/382184 Tian, 2010, Visualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopy, J Cell Biochem, 111, 488, 10.1002/jcb.22733 Korang-Yeboah, 2015, Polycaprolactone/maltodextrin nanocarrier for intracellular drug delivery: formulation, uptake mechanism, internalization kinetics, and subcellular localization, Int J Nanomed, 10, 4763 Gao, 2014, Internalization and subcellular fate of aptamer and peptide dual-functioned nanoparticles, J Drug Target, 22, 450, 10.3109/1061186X.2014.886038 Lou, 2015, Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma, J Hematol Oncol, 8, 122, 10.1186/s13045-015-0220-7